Redcare Phamacy Unsp/Adr (SAEYY) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Redcare Pharmacy N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.149 -- 00:00:05.830 Thank you very much and good morning to everybody and a very warm welcome from our side. 00:00:05.830 -- 00:00:09.031 Let's have a look into the agenda of today. 00:00:09.031 -- 00:00:14.471 First of all, we would like to talk about financial performance, then Rx and regulatory 00:00:14.471 -- 00:00:18.052 updates, and then guidance. 00:00:18.112 -- 00:00:22.913 If we start with the financial performance, let's look into the highlights of the Q1 00:00:22.913 -- 00:00:26.274 of 2026. Our revenues are 18% year 00:00:26.274 -- 00:00:28.554 over year up, 00:00:32.330 -- 00:00:37.914 We show strength in both segments with 19% for DACH and 16% 00:00:37.914 -- 00:00:40.074 for international. 00:00:40.316 -- 00:00:45.419 Our active customer base reached 14.2 million, up 1.1 00:00:45.419 -- 00:00:50.903 million year over year. And also our average basket size is up 9% year 00:00:50.903 -- 00:00:53.045 over year. 00:00:53.045 -- 00:00:56.986 Non-Rx revenue up 10% to 533 million. 00:00:58.491 -- 00:01:01.273 And then that's important and we will talk about this later. 00:01:01.273 -- 00:01:05.476 Growth in Germany accelerated from 5% in the Q4 of last year to 9% in Q1. 00:01:05.476 -- 00:01:08.318 Group Rx revenues are up 36% and in Germany 55% to 168 million. 00:01:08.318 -- 00:01:10.239 And also 00:01:10.239 -- 00:01:15.682 the ERX NPS further increased from 73 in Q4 of last year to now 76 in Q1 2026. 00:01:29.481 -- 00:01:34.626 Our adjusted EBITDA margin improved 0.4 percentage points year over year, 00:01:34.626 -- 00:01:37.908 reaching now 1.7%. Here 00:01:37.908 -- 00:01:43.291 we are fully on track to achieve our full year guidance. 00:01:44.054 -- 00:01:49.158 If we look into the segments, again, same number but some more details, 19...